Status:
RECRUITING
Sexual Dysfunction in Cirrhosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sexual Dysfunction in Patients With Cirrhosis Awaiting Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prevalence of erectile dysfunction (ED) is about 10% in the general population, but increases with age, ranging from 9.1% in men 40-49 years to 55% in men \>70. The major risk factors for ED are a...
Detailed Description
PREVALENCE OF ERECTILE DYSFUNCTION IN PATIENTS WITH CIRRHOSIS BEFORE AND AFTER LIVER TRANSPLANTATION. EFFECTIVENESS OF PHOSPHODIESTERASE-5 INHIBITORS. 1. Research objectives The aims of investigators...
Eligibility Criteria
Inclusion
- (1) cirrhosis; (2) non-urgent indication for LT.
Exclusion
- (1) clinical HE; (2) dementia; (3) language barrier; (4) past history of prostatic surgery
Key Trial Info
Start Date :
May 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 26 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05428267
Start Date
May 26 2023
End Date
January 26 2026
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'hépato-gastroentérologie Hôpital Pitié-Salpêtrière
Paris, France, 75013